MW
Matthew W. Davis
DELAYED 1 MONTH
Chief Development Officer
Aquestive Therapeutics, Inc.
Filings
1
Companies
1
Latest
Mar 9, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
No transactions to show.
Matthew W. Davis
Chief Development Officer
Filings
1
Companies
1
Latest
Mar 9, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
No transactions to show.